CLINICAL_TRIALS
trial_result
· 2024-06-26
Clinical Trial Update: A Chronic Pain Master Protocol (CPMP): A Study of LY3857210 In Participants With Osteoarthritis Pain [Phase 2]
Summary
Phase 2 trial of LY3857210 for osteoarthritis pain under the Chronic Pain Master Protocol has completed with results posted in June 2024.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Osteoarthritis | Phase 2 | Status: COMPLETED | Results posted: 2024-06-26